Mortality among third age patients with hip fracture and high cardiac risk

Zenaida Dedovic1, Adnana Talic-Tanovic, Halima Resic

  • 1Department for Anesthesiology and Resuscitation, Clinical Center of University of Sarajevo, Bosnia and Herzegovina. zenaidadedovic@yahoo.com

Insights

Surgical treatment for hip fractures in high-risk cardiac patients significantly reduces mortality. This approach is crucial for improving outcomes in elderly individuals with complex health conditions.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Orthopedic Surgery

Background:

  • Hip fracture mortality remains high despite medical advancements.
  • Aging populations are experiencing an increasing incidence of hip fractures.
  • Effective strategies are needed to mitigate mortality risks associated with hip fractures.

Purpose of the Study:

  • To evaluate the impact of surgical intervention on mortality rates in high-risk hip fracture patients.
  • To compare outcomes between surgically and conservatively treated hip fracture patients with cardiac risk factors.

Main Methods:

  • A retrospective-prospective study analyzed 66 patients aged 65-92 with hip fractures and high cardiac risk (based on the Lee index).
  • Patients were categorized into two groups: surgically treated and conservatively treated.
  • High-risk was defined as having three or more cardiac risk factors.

Main Results:

  • Operatively treated patients showed a lower incidence of renal insufficiency (2.9%) compared to conservatively treated patients (18.8%).
  • Demographic and overall risk factor distribution were similar between groups, except for renal insufficiency.
  • Surgical intervention was associated with improved outcomes in this high-risk cohort.

Conclusions:

  • Surgical treatment for hip fractures in patients with high cardiac risk is associated with reduced mortality.
  • This finding supports the consideration of surgical intervention for high-risk individuals to improve survival rates.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...